Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion type Assertion NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_head.
- NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion description "[In contrast to other FL, FL3B frequently lack CD10 expression (approximately 50% of cases), show lower probability of BCL2 expression (69% positive) and increased TP53 expression (31% positive).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_provenance.
- NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion evidence source_evidence_literature NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_provenance.
- NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion SIO_000772 21658612 NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_provenance.
- NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion wasDerivedFrom befree-2016 NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_provenance.
- NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_assertion wasGeneratedBy ECO_0000203 NP900767.RAj-FVIaQajdfA8oszdsCUtSnfAwt6YNx-LACIKNJLcYo130_provenance.